Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
18 mei 2015 - 08:07
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to present at Bio€quity Europe 2015 in Vienna
Bericht
Probiodrug to present at Bio€quity Europe 2015 in Vienna
HALLE/SAALE, Germany, 18 May 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Dr Hendrik Liebers, Chief Financial Officer, is scheduled to present at Bio€quity Europe on Tuesday, May 19th 2015 at 3.40pm CET at the InterContinental Vienna, Austria.
Datum laatste update: 21 februari 2026